Malignancy-Related Hypercalcemia
暂无分享,去创建一个
[1] Z. Şıklar,et al. Childhood Sustained Hypercalcemia: A Diagnostic Challenge , 2017, Journal of clinical research in pediatric endocrinology.
[2] P. Hoff,et al. Malignancy-Related Hypercalcemia in Advanced Solid Tumors: Survival Outcomes , 2017, Journal of global oncology.
[3] H. Demirbilek,et al. Severe Hypercalcemia in a Child With Acute Lymphoblastic Leukemia Relapse: Successful Management With Combination of Calcitonin and Bisphosphonate. , 2016, Journal of pediatric hematology/oncology.
[4] A. Mirrakhimov. Hypercalcemia of Malignancy: An Update on Pathogenesis and Management , 2015, North American journal of medical sciences.
[5] S. Korenman,et al. Multifactorial Hypercalcemia and Literature Review on Primary Hyperparathyroidism Associated with Lymphoma , 2014, Case reports in endocrinology.
[6] J. Riancho,et al. The clinical spectrum of hypocalcaemia associated with bone metastases , 1989, Journal of internal medicine.
[7] A. Benson,et al. Maintenance etidronate in the prevention of malignancy-associated hypercalcemia. , 1987, Archives of internal medicine.
[8] L. Mosekilde,et al. Etidronate disodium in the management of malignancy-related hypercalcemia. , 1987, The American journal of medicine.